Varicella-zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3143-3151

  Liu, XueQiao ^a   Li, Qingxue ^a   Dowdell, Kennichi ^a   Fischer, Elizabeth R ^a   Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VARICELLA ZOSTER VIRUS IE62 PROTEIN; VARICELLA ZOSTER VIRUS ORF12 PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DELETION MUTANT; EMBRYO; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; VARICELLA ZOSTER VIRUS; VIRION; VIRUS REPLICATION; WILD TYPE;

APOPTOSIS; CELL LINE; CHICKENPOX; HERPESVIRUS 3, HUMAN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OPEN READING FRAMES; PHOSPHORYLATION; VIRAL STRUCTURAL PROTEINS;

HUMAN HERPESVIRUS 3;

EID: 84863241919     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06923-11     Document Type: Article

References (35)

1. Brazeau E, et al. 2010. Varicella-zoster virus-induced apoptosis in MeWo cells is accompanied by down-regulation of Bcl-2 expression. J. Neurovirol. 16:133-140.
2. Che X, et al. 2008. Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J. Virol. 82:5825-5834.
3. Cohen JI, Cox E, Pesnicak L, Srinivas S, Krogmann T. 2004. The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J. Virol. 78:11833-11840.
4. Cohen JI, Krogmann T, Pesnicak L, Ali MA. 2007. Absence or overexpression of the varicella-zoster virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model. J. Virol. 81:1586 -1591.
5. Cohen JI, Seidel KE. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. U. S. A. 90:7376- 7380.
6. Hood C, et al. 2006. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J. Virol. 80:1025-1031.
7. Hood C, Cunningham AL, Slobedman B, Boadle RA, Abendroth A. 2003. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J. Virol. 77:12852-12864.
8. Jafri M, Donnelly B, McNeal M, Ward R, Tiao G. 2007. MAPK signaling contributes to rotaviral-induced cholangiocyte injury and viral replication. Surgery 142:192-201.
9. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911- 1912.
10. Kumar S, et al. 1996. Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase. J. Biol. Chem. 271:30864 -30869.
11. Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe DM. 2008. Herpesvirus tegument protein activates NF-κB signaling through the TRAF6 adaptor protein. Proc. Natl. Acad. Sci. U. S. A. 105:11335-11339.
12. Panousis CG, Rowe DT. 1997. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J. Virol. 71:4752- 4760.
13. Panteva M, Korkaya H, Jameel S. 2003. Hepatitis viruses and the MAPK pathway: is this a survival strategy? Virus Res. 92:131-140.
14. Perkins D, Pereira EF, Gober M, Yarowsky PJ, Aurelian L. 2002. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 76:1435-1449.
15. Pleschka S, et al. 2001. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305.
16. Rahaus M, Desloges N, Wolff MH. 2004. Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. J. Gen. Virol. 85:3529 -3540.
17. Rahaus M, Desloges N, Wolff MH. 2006. Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway. J. Gen. Virol. 87:749 -758.
18. Rahaus M, Wolff MH. 2003. Reciprocal effects of varicella-zoster virus (VZV) and AP1: activation of jun, fos and ATF-2 after VZV infection and their importance for the regulation of viral genes. Virus Res. 92:9 -21.
19. Renukaradhya GJ, Khan MA, Shaji D, Brutkiewicz RR. 2008. Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway. J. Virol. 82:12535- 12542.
20. Rinehart J, et al. 2004. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. J. Clin. Oncol. 22:4456-4462.
21. Roberts ML, Cooper NR. 1998. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240:93-99.
22. Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180 -186.
23. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68:320 -344.
24. Sadzot-Delvaux C, Thonard P, Schoonbroodt S, Piette J, Rentier B. 1995. Varicella-zoster virus induces apoptosis in cell culture. J. Gen. Virol. 76:2875-2879.
25. Schaap A, et al. 2005. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J. Virol. 79:12921-12933.
26. Smith CC. 2005. The herpes simplex virus type 2 protein ICP10PK: a master of versatility. Front. Biosci. 10:2820 -2831.
27. Straus SE, et al. 1981. Structure of varicella-zoster virus DNA. J. Virol. 40:516 -525.
28. Toschi E, et al. 2006. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol. Biol. Cell 17:1985-1994.
29. Willard M. 2002. Rapid directional translocations in virus replication. J. Virol. 76:5220 -5232.
30. Wortzel I, Seger R. 2011. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2:195-209.
31. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ. 2008. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371:139 -154.
32. Yu F, et al. 2007. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 3:e44.
33. Zapata HJ, Nakatsugawa M, Moffat JF. 2007. Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J. Virol. 81:977-990.
34. Zhang Z, et al. 2010. Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog. 6:e1000971.
35. Zhao LJ, et al. 2006. Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J. Leukoc. Biol. 80:424-432.